About Us

MedGenesis Therapeutix Inc. is a private Canadian biopharmaceutical holding company, with interests in seeing through to commercialization innovative treatments, including their various needed components.

Led by Dr. Erich Mohr, a recognized industry pioneer and expert in neurodegenerative disorders, who is supported by a Board of Directors with profound experience in the life sciences industry.

Mission Statement

MedGenesis Therapeutix Inc. is committed to support the commercialization of potentially innovative treatments for patients with serious neurologic disease, with a focus on Parkinson's disease.